Novozymes Biopharma AU Limited

Novozymes Biopharma AU Limited, headquartered in Australia, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Novonesis A/S, which provides emissions data and climate commitments at a higher corporate level. As of now, Novozymes Biopharma AU Limited has not outlined any specific reduction targets or initiatives in its own documentation. However, it is important to note that the climate commitments and performance metrics may be influenced by the broader sustainability strategies of Novonesis A/S, which is responsible for cascading relevant data and initiatives. The absence of detailed emissions data and reduction targets suggests that Novozymes Biopharma AU Limited may still be in the process of developing its own specific climate action plans. The company is part of an industry that increasingly prioritises sustainability and carbon footprint reduction, aligning with global efforts to combat climate change. For more comprehensive insights into their climate commitments, stakeholders may need to refer to the initiatives and targets set by Novonesis A/S, which may include participation in frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP).